Cas:2082-76-0 decanoyl decanoate manufacturer & supplier

Chemical Name:decanoyl decanoate

CAS.NO:2082-76-0

Synonyms:Decanoic acid,1,1′-anhydride;decanoic acid anhydride;n-Capric anhydride;DECANOIC ANHYDRIDE;n-Decanoic anhydride;Decansaeure-anhydrid;dicapryl ether;MFCD00010460;EINECS 218-213-4;Capric anhydride

Molecular Formula:C₂₀H₃₈O₃

Molecular Weight:326.51400

HS Code:2915900090

Physical and Chemical Properties:

Melting point:24-25 °C(lit.)

Boiling point:125-140 °C0.05 mm Hg(lit.)

Density:0.886 g/mL at 25 °C(lit.)

Index of Refraction:n20/D 1.44(lit.)

PSA:43.37000

Exact Mass:326.28200

LogP:6.33760

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3261 8/PG 2

Packing Group:

Contact us for information like Decanoic acid,1,1′-anhydride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Capric anhydride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Decanoic acid,1,1′-anhydride Use and application,n-Capric anhydride technical grade,usp/ep/jp grade.

Related News: What’s the background? decanoyl decanoate manufacturer Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms. decanoyl decanoate supplier Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. decanoyl decanoate vendor What’s the background? decanoyl decanoate factory Also, the study did not compare people who had COVID-19 with those who did not, to see if such symptoms were higher than in the general population. The report did exclude patients with certain serious or chronic preexisting conditions like cancer, kidney disease, HIV, liver disease and stroke, to separate their previous health status from post-COVID symptoms.